We're Not Worried About SyntekaBio's (KOSDAQ:226330) Cash Burn
Apr 07
South Korean (KOSPI) Healthtech Industry Analysis
UpdatedJan 31, 2023
DataAggregated Company Financials
Companies12
- 7D10.2%
- 3M33.3%
- 1Y-20.7%
- YTD26.9%
The Healthtech industry is up 10% in the last week, with UBcare up 29%. In contrast, the industry has lost 21% in the last 12 months.
Industry Valuation and Performance
Has the South Korean Healthtech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 31 Jan 2023 | ₩1.9t | ₩448.5b | -₩95,899,607,010.00 | 26x | -20.1x | 4.3x |
| Thu, 29 Dec 2022 | ₩1.6t | ₩448.5b | -₩95,899,607,010.00 | 23.1x | -16.2x | 3.5x |
| Sat, 26 Nov 2022 | ₩1.6t | ₩448.6b | -₩88,187,335,390.00 | 21.6x | -17.9x | 3.5x |
| Mon, 24 Oct 2022 | ₩1.1t | ₩437.6b | -₩42,477,231,270.00 | 18x | -25.8x | 2.5x |
| Wed, 21 Sep 2022 | ₩1.2t | ₩437.6b | -₩42,477,231,270.00 | 20x | -28.3x | 2.7x |
| Fri, 19 Aug 2022 | ₩1.4t | ₩433.8b | -₩36,565,870,330.00 | 24.3x | -38.6x | 3.3x |
| Sun, 17 Jul 2022 | ₩1.3t | ₩433.8b | -₩36,565,870,330.00 | 24.7x | -36.5x | 3.1x |
| Tue, 14 Jun 2022 | ₩1.5t | ₩424.4b | -₩29,952,843,950.00 | 26x | -50.6x | 3.6x |
| Thu, 12 May 2022 | ₩1.7t | ₩417.0b | -₩10,940,781,310.00 | 27.8x | -154.5x | 4.1x |
| Sat, 09 Apr 2022 | ₩1.9t | ₩417.0b | -₩10,940,781,310.00 | 30.8x | -171.5x | 4.5x |
| Mon, 07 Mar 2022 | ₩1.8t | ₩410.7b | -₩19,783,196,720.00 | 36.6x | -91.1x | 4.4x |
| Wed, 02 Feb 2022 | ₩1.8t | ₩410.6b | -₩18,656,947,590.00 | 35.2x | -96.4x | 4.4x |
| Fri, 31 Dec 2021 | ₩2.1t | ₩410.6b | -₩18,656,947,590.00 | 40.1x | -111.3x | 5.1x |
| Sun, 28 Nov 2021 | ₩2.0t | ₩408.7b | -₩6,856,516,160.00 | 37.1x | -284.7x | 4.8x |
| Tue, 26 Oct 2021 | ₩1.8t | ₩398.9b | -₩17,510,766,100.00 | 32.9x | -101.2x | 4.4x |
| Thu, 23 Sep 2021 | ₩2.0t | ₩398.9b | -₩17,510,766,100.00 | 35.1x | -113.3x | 5x |
| Sat, 21 Aug 2021 | ₩1.9t | ₩398.9b | -₩17,510,766,100.00 | 32.7x | -107.5x | 4.7x |
| Sat, 05 Jun 2021 | ₩1.8t | ₩385.0b | -₩11,156,047,410.00 | 28.1x | -160.4x | 4.6x |
| Tue, 09 Mar 2021 | ₩1.6t | ₩378.3b | -₩3,223,886,080.00 | 30.9x | -483.9x | 4.1x |
| Mon, 30 Nov 2020 | ₩1.8t | ₩370.8b | -₩7,829,411,370.00 | 44.8x | -230.6x | 4.9x |
| Thu, 03 Sep 2020 | ₩1.8t | ₩362.7b | -₩3,185,793,380.00 | 44.1x | -560.5x | 4.9x |
| Sun, 07 Jun 2020 | ₩1.6t | ₩365.3b | -₩19,027,826,430.00 | 50x | -83.4x | 4.3x |
| Sat, 29 Feb 2020 | ₩1.0t | ₩356.7b | -₩17,599,124,030.00 | 27.1x | -57.6x | 2.8x |
Price to Earnings Ratio
-63.1x
Current Industry PE
- Investors are relatively neutral on the South Korean Health Care Technology industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 4.1x.
Past Earnings Growth
- The earnings for companies in the Health Care Technology industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 7.9% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Comparison
How does South Korean Healthtech compare with similar industries?
| KR Market | 2.46% | |
| Healthcare | 0.63% | |
| Healthtech | 10.16% | |
| Healthtech | 10.16% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A032620 UBcare | ₩6.80k | 29.0% +₩77.6b | 6.4% | PE52.1x | |
| A328130 Lunit | ₩39.65k | 7.2% +₩32.4b | n/a | PS34.6x | |
| A099750 ezCaretech | ₩29.40k | 19.8% +₩30.4b | -19.5% | PS2.2x | |
| A263700 CarelabsLtd | ₩8.20k | 17.1% +₩21.8b | 1.2% | PS1.6x | |
| A226330 SyntekaBio | ₩9.89k | 14.9% +₩17.3b | -30.1% | PS437.4x |